StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HCWC$0.37+10.51%
Fair $0.37+0.0%

HCWC

Healthy Choice Wellness Corp.

Consumer Defensive / Packaged FoodsNYSE American

$0.37

+0.03 (+10.51%)

Fairly Valued+0.0%Fair Value $0.37Fund rank 23/100 · Data gapFallback financials|
SA 24/D
F-Score: 6/9
High DebtLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-2.7M · quality 36.3/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 29/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Debt-to-Equity ratio is 2.47, above the 2.0 threshold ROE is -53.9%, below the 5% threshold
Thesis & Journal · HCWCLocal privado en este navegador · Healthy Choice Wellness Corp.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$10M

P/E

N/A

•

EV/EBITDA

8.9x

↑

ROE

-53.9%

↓

Gross Margin

39.2%

↑

Debt/Equity

2.47

↑
52-Week Range$0
$0$1

TradingView lightweight chart

HCWC price, volumen y niveles de valoración

Último $0.368Periodo -93.0%
Fair value: $0.368

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+39.2%

FCF CAGR

—

FCF margin

0.9%

FCF / Net income

-0.17x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $78.2M · net income $-3.9M · FCF $675420.0

2022-FY → 2025-FY

Gross margin

39.2%+4.4% pts

Operating margin

-3.2%+11.2% pts

Net margin

-5.0%+6.4% pts

FCF margin

0.9%+6.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$78.2M$78.2M$69.4M$55.7M$29.0M
Net Income$-3.9M$-3.9M$-4.5M$-9.9M$-3.3M
EBITDA$2.5M$2.5M$1.2M$-5.7M$-1.2M
EPS——-0.48-1.08-0.35
Gross Margin39.2%39.2%39.0%36.5%34.8%
Operating Margin-3.2%-3.2%-2.9%-7.9%-14.4%
Net Margin-5.0%-5.0%-6.5%-17.8%-11.5%
Balance Sheet
Debt/Equity2.472.4710.721.590.85
Current Ratio0.680.68———
Cash Flow
Free Cash Flow$675420.00$675420.00$-3.3M$-2.7M$-1.8M
Returns
ROE-53.9%-53.9%-189.3%-110.5%-21.4%
Valuation
EV/EBITDA8.868.8628.34——
P/B1.011.014.34——
Growth & Yield
Revenue Growth12.7%12.7%24.6%92.0%—
EPS Growth——55.4%-204.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -7.1%

Total return

-7.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.48 → n/d

Residual

-7.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-7.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.